David N. Orth
#126,902
Most Influential Person Now
David N. Orth's AcademicInfluence.com Rankings
David N. Orthbiology Degrees
Biology
#8094
World Rank
#11115
Historical Rank
Neuroscience
#1100
World Rank
#1142
Historical Rank
Download Badge
Biology
Why Is David N. Orth Influential?
(Suggest an Edit or Addition)David N. Orth's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. (1996) (531)
- Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. (1999) (491)
- Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. (1983) (423)
- Cushing's syndrome. (1995) (405)
- Epidermal growth factor: effects of androgens and adrenergic agents. (1974) (396)
- Results of treatment in 108 patients with Cushing's syndrome. (1971) (298)
- Rapid radioimmunoassay for corticotropin in unextracted human plasma. (1984) (286)
- Corticotropin-releasing hormone in humans. (1992) (285)
- Clinical and laboratory studies of ectopic humoral syndromes. (1969) (266)
- Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. (1983) (242)
- Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. (1985) (233)
- Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). (1981) (220)
- Radioimmunoassay of epidermal growth factor. (1972) (220)
- Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. (1984) (196)
- Epidermal growth factor: identification of a new hormone in human urine. (1975) (192)
- Radioimmunoassay of human epidermal growth factor (urogastrone). (1977) (189)
- Results of treating childhood Cushing's disease with pituitary irradiation. (1977) (188)
- Epidermal growth factor (urogastrone) in human fluids: size heterogeneity. (1979) (186)
- Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. (1987) (182)
- Epidermal growth factor (urogastrone) in human tissues. (1979) (176)
- Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. (1973) (166)
- Experimental alteration of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. (1967) (150)
- Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. (1982) (147)
- Individual differences in repressive-defensiveness predict basal salivary cortisol levels. (1996) (145)
- Homologous radioimmunoassay for human epidermal growth factor (urogastrone). (1978) (140)
- Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. (1982) (139)
- Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. (1988) (127)
- Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man. (1980) (125)
- Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. (1971) (124)
- Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses. (1982) (118)
- Light synchronization of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. (1969) (111)
- Human placental immunoreactive corticotropin, lipotropin, and beta-endorphin: evidence for a common precursor. (1979) (110)
- Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. (1992) (110)
- Concentrations of epidermal growth factor, nerve growth factor, and submandibular gland renin in male and female mouse tissue and fluids. (1979) (107)
- Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression (1997) (103)
- Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. (1988) (102)
- Normal and abnormal regulation of β-MSH in man (1969) (100)
- Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome. (1973) (97)
- Psychiatric phenomenology in Cushing's disease. (1992) (97)
- Specific demonstration of the human hypophyseal adrenocortico-melanotropic (ACTH-MSH) cell. (1974) (96)
- Ontogeny of neuroendocrine cells in human fetal lung. II. An immunohistochemical study. (1985) (94)
- Effect of mouse epidermal growth factor/urogastrone on the functional maturation of rat intestine. (1983) (94)
- Submaxillary gland epidermal growth factor: a sensitive index of biologic androgen activity. (1974) (93)
- Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. (1989) (93)
- Radioimmunoassay of β-MSH in Human Plasma and Tissues* (1967) (92)
- Corticotropin, lipotropin, and beta-endorphin production by a human nonpituitary tumor in culture: evidence for a common precursor. (1978) (88)
- Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine corticotropin-releasing factor and arginine vasopressin. (1987) (87)
- Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues. (1988) (87)
- Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects. (1985) (87)
- FREE‐RUNNING CIRCADIAN PLASMA CORTISOL RHYTHM IN A BLIND HUMAN SUBJECT (1979) (86)
- The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions. (1975) (84)
- Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. (1991) (84)
- Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone. (1985) (83)
- Epidermal growth factor in human milk: daily production and diurnal variation during early lactation in mothers delivering at term and at premature gestation. (1983) (83)
- Specific demonstration of the human hypophyseal cells which produce adrenocorticotropic hormone. (1970) (83)
- Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome. (1989) (82)
- Primary hypoadrenocorticism in ten cats. (1989) (82)
- Ectopic production of high molecular weight calcitonin and corticotropin by human small cell carcinoma cells in tissue culture: evidence for separate precursors. (1978) (79)
- 12 – Adrenocorticotropic Hormone (ACTH) (1978) (77)
- Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. (1987) (72)
- Cerebrospinal fluid and plasma β-endorphin in combat veterans with post-traumatic stress disorder (1997) (69)
- Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. I. Corticotropin-releasing factor stimulation. (1990) (67)
- Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. (1995) (66)
- Diurnal rhythm and disappearance half-time of endogenous plasma immunoreactive beta-MSH (LPH) and ACTH in man. (1978) (64)
- Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred. (1979) (63)
- Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations. (1986) (62)
- A pituitary parasellar tumor with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides. (1983) (61)
- Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol. (1983) (59)
- Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. (1991) (59)
- Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor. (1978) (58)
- Metyrapone is useful only as adjunctive therapy in Cushing's disease. (1978) (55)
- The nature of the immunoreactive lipotropins in human plasma and tissue extracts. (1978) (55)
- ACTH and MSH production by a single cloned mouse pituitary tumor cell line. (1973) (52)
- Preliminary characterization of the pituitary melanocyte stimulating hormones of several vertebrate species. (1972) (52)
- Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease. (1982) (51)
- A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse. (1979) (51)
- The old and the new in Cushing's syndrome. (1984) (51)
- High molecular weight forms of human ACTH are glycoproteins. (1977) (50)
- Glucocorticoid receptors in pituitary tumor cells. I. Cytosol receptors. (1973) (49)
- Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. (1996) (49)
- Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man. (1983) (48)
- Urinary TGFs1 in neoplasia: immunoreactive TGF-alpha in the urine of patients with disseminated breast carcinoma. (1987) (47)
- Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells. (1973) (47)
- Stimulation of adrenal ornithine decarboxylase by adrenocorticotropin and growth hormone. (1973) (47)
- Secretion of ACTH and -MSH by an adrenal medullary paraganglioma. (1972) (47)
- Evidence for glucocorticoid transport into AtT-20/D-1 cells. (1975) (44)
- Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man. (1984) (44)
- Lymphocyte-derived adrenocorticotropin is insufficient to stimulate adrenal steroidogenesis in hypophysectomized rats. (1992) (44)
- Hormonal regulation of renal ornithine decarboxylase activity in the rat. (1976) (43)
- Circulating big human prolactin: conversion to small human prolactin by reduction of disulfide bonds. (1979) (41)
- Simultaneous Assay of Immunoreactive β-Lipotropin, γ-Lipotropin, and β-Endorphin in Plasma of Normal Human Subjects, Patients with ACTH/Lipotropin Hypersecretory Syndromes, and Patients undergoing Chronic Hemodialysis (1981) (40)
- Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. (1973) (40)
- Conversion of high molecular weight human epidermal growth factor (hEGF)/urogastrone (UG) to small molecular weight hEGF/UG by mouse EGF-associated arginine esterase. (1979) (40)
- Evidence for glucocorticoid transport through the target cell membrane. (1974) (40)
- DIFFERENT MOLECULAR FORMS OF ACTH * (1977) (39)
- Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. II. Arginine vasopressin, oxytocin, and angiotensin-II stimulation. (1990) (39)
- Adrenocortical dysplasia: a mouse model system for adrenocortical insufficiency. (1994) (38)
- Immunoreactive human epidermal growth factor concentrations in amniotic fluid, umbilical artery and vein serum, and placenta in full-term and preterm infants. (1989) (37)
- Beta-endorphin inhibits glucose production in the conscious dog. (1984) (36)
- Role of protein kinase-C in the adrenocorticotropin secretory response to arginine vasopressin (AVP) and the synergistic response to AVP and corticotropin-releasing factor by perifused rat anterior pituitary cells. (1990) (35)
- Effects of intracellular Ca2+ depletion and glucocorticoid on stimulated adrenocorticotropin release by rat anterior pituitary cells in a microperifusion system. (1991) (35)
- ACTH-secreting medullary carcinoma of the thyroid presenting a severe idiopathic osteoporosis and senile purpura: report of a case and review of the literature. (1978) (35)
- ACTH antibodies in patients receiving depot porcine ACTH to hasten recovery from pituitary-adrenal suppression. (1967) (33)
- Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system. (1989) (33)
- Glucocorticoid receptors in mouse pituitary tumor cells. II. Nuclear binding. (1974) (32)
- Differences between ectopic MSH and pituitary MSH. (1971) (31)
- Effects of several in vitro systems on the potencies of putative adrenocorticotropin secretagogues on rat anterior pituitary cells. (1988) (31)
- Cowden disease: gene marker studies and measurements of epidermal growth factor. (1986) (31)
- Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism (1993) (30)
- Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies. (1994) (30)
- A case of ectopic ACTH syndrome: diagnostic difficulties caused by intermittent hormone secretion. (1982) (30)
- Role of lipoxygenase metabolites of arachidonic acid in the regulation of adrenocorticotropin secretion by perifused rat anterior pituitary cells. (1994) (29)
- Ectopic production of antidiuretic hormone (adh), adrenocorticotrophic hormone (ACTH) and beta-melanocyte stimulating hormone (beta-MSH) by an oat cell carcinoma of the lung. (1977) (29)
- Abnormalities of platelet-derived growth factors in insulin-dependent diabetes. (1985) (29)
- Pituitary and hypothalamic hormones in normal and neoplastic adrenal medullae: biologically active corticotropin-releasing hormone and corticotropin (1987) (28)
- Characterization of a high-molecular-weight form of epidermal growth factor in an extract of human urine. (1987) (28)
- Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli. (1988) (28)
- The effect of cell membrane alteration on glucocorticoid uptake by the AtT-20/D-1 target cell. (1977) (28)
- The mechanism of ACTH stimulation of adrenal ornithine decarboxylase activity. (1975) (27)
- The response of plasma immunoreactive adrenocorticotropin, beta-endorphin/beta-lipotropin, gamma-lipotropin and cortisol to experimentally induced pain in normal subjects. (1982) (26)
- Effect of beta-lipotropin on aldosterone production in the isolated rat adrenal cell preparation. (1982) (26)
- Ectopic pro-opiolipomelanocortin: sequence of cDNA coding for beta-melanocyte-stimulating hormone and beta-endorphin. (1983) (25)
- Cerebrospinal fluid and plasma beta-endorphin in combat veterans with post-traumatic stress disorder. (1997) (25)
- Purification and characterization of epidermal growth factor (beta-urogastrone) and epidermal growth factor fragments from large volumes of human urine. (1985) (25)
- Multiple glucocorticoid binding components of intact AtT-20/D-1 mouse pituitary tumor cells. (1976) (24)
- Secretion of epidermal growth factor, nerve growth factor, and renin-like enzymes by dispersed male mouse submandibular gland cells in vitro. (1980) (24)
- Differential diagnosis of Cushing's syndrome. (1991) (24)
- ACTH RADIOIMMUNOASSAY: INTERPRETATION, COMPARISON WITH BIOASSAY, AND CLINICAL APPLICATION. (1969) (24)
- Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor. (1987) (24)
- Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism. (1983) (23)
- Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I. (1993) (22)
- THE EFFECT OF INSULIN, ALLOXAN DIABETES, AND ANOXIA ON THE ULTRASTRUCTURE OF THE RAT HEART (1962) (22)
- Tumors of the Adrenal Cortex and Cushing's Syndrome (1985) (22)
- Cushing's disease without hypercortisolism. (1970) (22)
- Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man. (1989) (22)
- Preprothyrotropin-releasing hormone-(178-199) does not inhibit corticotropin release. (1996) (21)
- Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression. (2001) (21)
- Binding of cytosol receptor-glucocorticoid complexes by isolated nuclei of glucocorticoid-responsive and nonresponsive cultured cells. (1976) (21)
- Establishment of human malignant melanoma clonal cell lines that secrete ectopic adrenocorticotropin. (1973) (21)
- Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol. (1987) (21)
- Effect of Epidermal Growth Factor and Artificial Feeding in Suckling Rats (1986) (20)
- Effect of synthetic ovine corticotropin-releasing factor: Prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol (1984) (19)
- Intestinal Glucose Transport in Suckling Rats Fed Artificial Milk with and without Added Epidermal Growth Factor (1987) (19)
- Human urinary epidermal growth factor excretion: age, sex, and race dependence. (1988) (19)
- Role of inositol trisphosphate-sensitive calcium stores in the regulation of adrenocorticotropin secretion by perifused rat anterior pituitary cells. (1995) (18)
- Ophthalmoplegia resulting from diphenylhydantoin and primidone intoxication (1967) (18)
- Evidence for structural dissociation of two biologic actions of growth hormone. (1975) (18)
- Decreased levels of hepatic epidermal growth factor receptors in obese hyperglycemic rodents. (1987) (17)
- Human γ-Lipotropin Radioimmunoassay: Identification of Immunoreactive γ-Lipotropin in Human Plasma and Tissue (1981) (17)
- Adrenal function in abstinent alcoholic men (1991) (16)
- MOLECULAR WEIGHT FORMS OF IMMUNOREACTIVE CALCITONIN IN A PATIENT WITH MEDULLARY CARCINOMA OF THE THYROID: DYNAMIC STUDIES WITH CALCIUM, PENTAGASTRIN AND SOMATOSTATIN (1980) (16)
- DOSE RESPONSE OF PLASMA ADRENOCORTICOTROPIN AND CORTISOL (1983) (15)
- Clinical studies with synthetic ovine corticotropin-releasing factor. (1985) (15)
- Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration. (1985) (15)
- NH2-terminal amino acid sequence and peptide mapping of purified human beta-lipotropin: comparison with previously proposed sequences. (1982) (15)
- 13 – Melanocyte-Stimulating Hormones (MSH's) and Lipotropic Hormones (LPH's) (1978) (15)
- Isolated deficiency of adrenocorticotropin (ACTH) and lipotropins (LPHs). (1978) (15)
- The Cushing Syndrome: Quest for the Holy Grail (1994) (14)
- Cell-free synthesis of mouse corticotropin. Evidence for two high molecular weight gene products. (1979) (14)
- Evidence for renotropic activity in ovine pituitaries. (1979) (14)
- Human A673 cells secrete high molecular weight EGF‐receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF‐α (1986) (14)
- Thyroid and Adrenal Dysfunction in Abstinent Alcoholic Men: Locus of Disturbance (1993) (14)
- Hypercortisolism, diarrhea with steatorrhea, and massive proteinuria due to pheochromocytoma. (1985) (13)
- Plasma concentrations of immunoreactive proopiomelanocortin peptides and cortisol in clinically normal cats. (1994) (13)
- Ophthalmoplegia Resulting From Diphenylhydantoin and Primidone Intoxication: Report of Four Cases (1967) (13)
- Murine leukaemia C-type virus associated with functional murine carcinomas of endocrine origin. (1971) (12)
- Proopiomelanocortin gene expression in a pheochromocytoma using upstream transcription initiation sites. (1988) (12)
- Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency. (1992) (12)
- General considerations for radioimmunoassay of peptide hormones. (1975) (11)
- The effect of feeding on cerebrospinal fluid corticotropin-releasing hormone levels in humans (2001) (9)
- Chromogranin A does not mediate glucocorticoid inhibition of adrenocorticotropin secretion. (1993) (8)
- Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors. (1988) (8)
- Effect of protein kinase-C depletion on inositol trisphosphate-mediated and cyclic adenosine 3',5'-monophosphate-dependent protein kinase-mediated adrenocorticotropin secretion. (1993) (8)
- Tissue-specific stimulation of ornithine decarboxylase activity by pituitary factors immunologically related to growth hormone. (1977) (8)
- Nature of the increase in renal ornithine decarboxylase activity after cycloheximide administration in the rat. (1975) (7)
- Epidermal growth factor in human milk and the effects of systemic EGF injection on intestinal calcium transport in suckling rats. (1986) (6)
- The detection of "purified" incubation damage by several radioimmunoassay separation methods. (1978) (6)
- ASSAY OF ACTH: DISCUSSION (1977) (5)
- Mechanism of syncytium formation between XC sarcoma cells and murine endocrine carcinoma cells. (1972) (5)
- Corticotropin-releasing hormone: stimulation of ACTH secretion in normal man. (1987) (5)
- Ectopic production of ACTH, lipotropin, and beta-endorphin by human cancer cells. Structurally related tumor markers. (1979) (5)
- Radioimmunoassay of beta-MSH in human plasma and tissues. (1967) (5)
- Hyperpigmentation Due Solely to Increased Plasma ß-Melanotropin (1970) (5)
- Intra‐ and inter‐individual correlations between cholecystokinin and corticotropin‐releasing hormone concentrations in human cerebrospinal fluid (1999) (4)
- A challenge to the concept that ACTH affects growth hormone secretion in man. (1972) (4)
- Prokaryotic adenylate cyclase toxin stimulates anterior pituitary cells in culture. (1986) (4)
- Normal and abnormal regulation of beta-msh in man. (1969) (4)
- Combined primary and secondary adrenocortical failure. (1982) (4)
- Pituitary response to intravenous hypothalamic releasing peptides in cynomolgus monkeys treated with contraceptive steroids. (1987) (4)
- Evaluation of Pituitary-Adrenal Function in Man (1967) (3)
- Plasma immunoreactive beta-melanocyte stimulating hormone (lipotropin) levels in individuals with Prader-Labhart-Willi syndrome. (1987) (3)
- Adrenal insufficiency. (1994) (3)
- Molecular size and plasma levels of immunoreactive beta-MSH under physiological and pathological conditions in man. (1977) (3)
- Radioimmunoassay of P-MSH in Human Plasma and Tissues (2)
- Heavy-particle treatment of Cushing's disease. (1971) (2)
- Method for preparation of ampoules containing microgram quantities of polypeptide hormones for distribution and use as laboratory standards: synthetic human ACTH and beta-MSH. (1976) (2)
- Multiple Recurrent Carcinoid Tumors That Secreted Adrenocorticotropin (ACTH) Over a Period of 26 Years (1994) (2)
- Two distinct insulin-related molecules in the guinea pig: immunological and biochemical characterization of insulin-like immunoactivity from extrapancreatic tissues of the guinea pig (1985) (2)
- Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis. (1981) (2)
- Dissociation of the plasma disappearance of bioactive and immunoreactive ACTH from human plasma. (1970) (1)
- UMBILICAL ARTERY (UA), UMBILICAL VEIN (UV) AND MATCHED PLACENTAL CONCENTRATIONS OF HUMAN EPIDERMAL GROWTH FACTOR (hEGF) IN FULL TERM (FT) AND PREMATURE INFANTS (PT) (1984) (1)
- Human gamma-lipotropin radioimmunoassay: identification of immunoreactive gamma-lipotropin in human plasma and tissue. (1981) (1)
- Human placental immunoreactive corticotropin, lipotropin, and f3-endorphin: Evidence for a common precursor (radioimmunoassay/gel exclusion chromatography/gel electrophoresis/immune affinity chromatography) (0)
- Mechanisms of hypoglycemic counterregulation in Addison's disease (1996) (0)
- Detection of ''purified'' incubation damage by several radioimmunoassay separation methods. [Melanocyte-Stimulating hormone] (1978) (0)
- Subject Index Vol. 60, 1994 (1994) (0)
- [Ectopic secretion of ACTH and of related peptides (LPHs, beta-endorphin, "16K"). Evidence for a common precursor]. (1980) (0)
- The Cushing Syndrome (1995) (0)
- Citation for the 1999 Sidney H. Ingbar Distinguished Service Award of the Endocrine Society to Dr. M. Susan Smith. (1999) (0)
- Simultaneous Assay of Immunoreactive f3-Lipotropin, (1981) (0)
- THE CUSHING SYNDROME. AUTHOR REPLY (1995) (0)
- Cerebrospinal Fluid and Plasma β‐Endorphin in Combat Veterans with Posttraumatic Stress Disorder a (1997) (0)
- Hyperpigmentation due solely to increased plasma beta-melanotropin. (1970) (0)
- Citation for the 1997 Robert H. Williams Distinguished Leadership Award of The Endocrine Society to Dr. Hiroo Imura. (1997) (0)
- Current concepts concerning the pathogenesis of the hyperthyroidism of Graves' disease. (1967) (0)
- Normal and abnormal regulation of b-MSH in man (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David N. Orth?
David N. Orth is affiliated with the following schools:
